Moreover, the AURKA expression of the cells treated with CHOP (0, 10, 20 and 40 ng/mL) was also detected, and there was no obvious difference in AURKA expression between cells in Control group and CHOP group (Figure 3(c,d)), denoting that CHOP suppressed the cell viability and had no obvious effects on AURKA expression in DLBCL cells. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.